Compound 121564
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Compound 121564, covering 2018-08-14 to 2018-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer [Phase 2]